A couple of comments on the ann. report
"Co. Vision -Eastland Medical Systems Ltd is an Australian drug delivery business that looks to develop and commercialise a range of innovative patient and clinician preferred, patented products for global markets using patented technology to administer drugs through the sublingual route"
Well, I interpret this as meaning that EMS in the future will again hookup with PP / LP sublingual (patented) technology and combining it with another (patented) non malaria medicine.
"On 10 August 2012 the Company issued 610,000 secured Convertible Notes with an expiry date of 30 June 2014 with attaching options to raise $610,000 before expenses. A related party has expressed interest in acquiring an additional 150,000 Convertible Notes and attaching options. The issue of these notes to a related party are subject to shareholder approval.
I wouldn't be surprised if the 'related party' is LP?
bluebush
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable